Safety and efficacy of immune checkpoint inhibitors and hypomethylating agents in treatment-naïve AML and HR-MDS: a systematic review and HR-MDS meta-analysis

Cancer Treatment and Research Communications · Elsevier

Аннотация

Publication date: 2026 Source: Cancer Treatment and Research Communications, Volume 49 Author(s): Zahra Khoshnegah, Mehrdad Rostami, Mohammad Navid Khaksari, Mohammad Hossein Khazaee-Nasirabadi, Fatemeh Arianmanesh, Fatemeh Jafarnejad, Alireza Khiabani, Ali Sadatmoosavi, Saeed Zanganeh, Fatemeh Shahabi Nezhad, Muhammad Hossein Ashoub, Abdollah Jafarzadeh

Читать у издателя →

Похожие статьи